Since the study ended too early to see major effects on Tau pathology (PHF-1-immunoreactive dystrophic neurites or neurofibrillary tangles), it is recommended to explore the long-term effects of HLJDT-M on Tau pathology in aged 3xTg-AD mice. Here, MAPT is linked to Alzheimer disease.